The tweet was deleted by the author.
But we saved everything 🙂.
Twist Bioscience is involved in genomic sequencing for recent outbreak response activities, according to Twist Bioscience.
Twist Bioscience stated its Comprehensive Viral Research Panel is being used in the preliminary analysis of Orthohantavirus andesense virus.
TWST is trading well above its MA-20 ($62.17), MA-50 ($58.23), and MA-200 ($41.37), reinforcing short-, medium-, and long-term bullish trends. The Ichimoku Kijun level on D1 sits at $64.27, indicating immediate support just below the current price. Near-term support is seen at the Ichimoku Kijun ($64.27) and MA-20 ($62.17), while key support levels are at MA-50 ($58.23) and MA-100 ($52.27). Near-term resistance comes in at MA-5 ($71.12), and key resistance is at MA-10 ($69.37).
Momentum, as measured by MACD and ADX on D1, remains robustly positive, with MACD in buy territory and ADX confirming a bullish tone. RSI and CCI are both positioned in the buy zone, and CCI is just entering overbought territory. Stoch RSI is neutral on D1 but flashes overbought or oversold on shorter and weekly timeframes, signaling some underlying divergence. BBP is classified as overbought, with buyers dominating the recent session, while the Awesome Oscillator is also supportive of a bullish move. Over the past week, TWST is trading at $70.06, up from a prev_week_close of $69.22, reflecting a 1.21% gain. The current price is in the lower part of the weekly range, while weekly volatility stands at a high 21.13%. This pattern suggests recovery off the week’s low but a pullback from the week’s high, with conflicting short-term oscillator signals tempering the otherwise bullish momentum.
For the coming week, the expected price range is $66.00 to $74.00, keeping the forecast within 10% of the current price and consistent with recent volatility. With four consecutive Buy or Strong Buy signals from RSI-W1, ADX-W1, MACD-W1, and MA-50-W1, the probability of further price increases is very high (more than 80%), making a decline less likely. In the baseline scenario, TWST remains sideways between $66.00 and $74.00. A bullish scenario would see a breakout above $74.00, targeting fresh highs near resistance and testing the upside boundaries set by the yearly range ($23.30 to $80.50). Conversely, a bearish reversal below $66.00 could trigger a retest of the $64.00–$62.00 support cluster, closer to the rising trend on both the daily and weekly charts. The forecasted range remains well above the 52-week low and still within reach of yearly highs, reflecting the sustained upward momentum in the broader move.
Earlier, analysts noted that Twist Bioscience maintained a strong bullish trend supported by positive momentum indicators despite brief volatility. This article adds a new dimension by assessing how recent market developments may shift the prevailing scenario, with traders advised to watch for a confirmed breakout above near-term resistance to validate continued upside momentum.